Integrating Metabolomics and Machine Learning Reveals Metabolic Signatures and Candidate Biomarkers for Vestibular Migraine

Vestibular migraine (VM) is an underrecognized disorder characterized by episodic vertigo, often accompanied by headache. Despite its substantial prevalence and disease burden, its metabolic features remain poorly characterized, and serum biomarkers for diagnosis or activity assessment are lacking....

Continue reading at PubMed →

No actionable change for current audiology or vestibular clinical practice; candidate biomarkers are experimental and not validated for diagnostic use—this is early-stage translational research.

Reliable biomarkers for vestibular migraine would transform diagnosis from a purely symptom-based process to an objective one, potentially reducing the diagnostic odyssey for patients with episodic dizziness.

1. 01Combined metabolomics (chemical profiling of body fluids) and machine learning to identify vestibular migraine biomarkers.
2. 02Vestibular migraine is currently diagnosed by clinical criteria alone, with no validated objective test.
3. 03Study identified metabolic signatures distinguishing vestibular migraine from controls or other diagnoses.
4. 04Machine-learning models improve biomarker pattern recognition but require external validation before clinical use.
5. 05Published in Journal of Proteome Research; early-stage translational science.

PMID

42918111

DOI

10.1021/acs.jproteome.6c00143.

Journal

Journal of Proteome Research

Publication type

research_article

Evidence level

4

Population

Patients with vestibular migraine compared to controls or other vestibular/headache disorder patients

Intervention

Metabolomic profiling with machine-learning analysis

Comparator

Non-vestibular migraine controls or other vestibular disorder patients